在基本震中,普拉诺洛尔和普里米对震调节作用的机制
Katarina Vogelnik Žakelj1, Neža Prezelj2, Milica Gregorič Kramberger3
1Department of Neurology, University Medical Centre Ljubljana, Ljubljana, Slovenia; Institute of Clinical Neurophysiology, University Medical Centre Ljubljana, Ljubljana, Slovenia.
Parkinsonism & related disorders
|September 25, 2024
概括
普里米和普拉诺洛尔通过改变大脑兴奋能力来减少基本震. 普里米多是一种原.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 临床神经学 临床神经学
背景情况:
- 基本震 (ET) 是一种常见的神经疾病.
- 普里米和普拉诺洛尔是ET的第一线治疗方法.
- 这些ET药物的作用机制尚未完全理解.
研究的目的:
- 为了研究ET中普利米和普罗普拉诺洛尔的神经生理机制.
- 探索皮层脊髓和皮层内刺激能力的跨磁刺激 (TMS) 测量方法.
- 评估眼的经典条件 (EBCC) 作为治疗反应的预测指标.
主要方法:
- 54名ET患者的前性观察研究.
- 评估包括临床和加速度计震评估.
- TMS评估了皮质脊髓刺激能力 (运动值,I/O曲线) 和皮质内刺激能力 (CSP,SICI,LICI,ICF,SAI). 在基线时测量了EBCC.
主要成果:
- 普里米降低了震,与皮质脊髓刺激能力的降低,延长CSP,增加LICI,增加SAI和降低SICI有关.
- 普拉诺洛尔减少了震,与皮质脊髓刺激性降低和SAI增加有关.
- 更好的基线EBCC预测了对普里米的优异反应.
结论:
- 普里米的有效性涉及通道阻塞和GABAergic电路的调节.
- 兰醇的核心作用可能源于GABA的诺亚能调节.
- 在ET中,EBCC可以作为预测primidone反应的生物标志物.
相关概念视频
Anxiolytic Drugs: Overview
238
Anxiolytic drugs are vital in managing anxiety disorders by effectively alleviating symptoms such as excessive fear, tachycardia, and tremors. There are several classes of anxiolytic medications, each with unique mechanisms of action and potential side effects.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...
238
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
274
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
274
Sedatives and Hypnotics Drugs: Miscellaneous Agents
157
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
157
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
266
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
266
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
635
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
635
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
542
β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in...
542


